|1||NCT00774358||Completed||Interleukin-2 Treatment for Wiskott-Aldrich Syndrome||
||9||All||24 Months and older (Child, Adult, Senior)||NCT00774358||2007-6-5354
|WAS||October 2008||September 2016||September 2016||October 17, 2008||August 16, 2017||
|2||NCT00909363||Active, not recruiting||Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients||
||Other / Industry||
||19||Male||3 Months to 80 Years (Child, Adult, Senior)||NCT00909363||0801009600||WAS||June 2009||May 2019||June 2020||May 28, 2009||February 2, 2017||
† Study has passed its completion date and status has not been verified in more than two years.